Neoadjuvant and Adjuvant Trials in Non–Small Cell Lung Cancer
- 31 January 1998
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 65 (1) , 208-211
- https://doi.org/10.1016/s0003-4975(97)01150-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 diseaseBritish Journal of Cancer, 1996
- Multimodality therapy in stage III non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patientsCancer, 1995
- Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non‐small cell lung cancerJournal of Surgical Oncology, 1994
- Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Neoadjuvant Therapy of Stage III Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 1988
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.Journal of Clinical Oncology, 1986
- Carcinoma of the Lung: Results of Treatment over Ten YearsThe Annals of Thoracic Surgery, 1976
- Postresection Irradiation for Primary Lung CancerRadiology, 1975